Breaking News

Ono Expands Investment in Ono Venture Fund to $200M

Aims to accelerate open innovation and make strategic investments in bio-venture companies.

Ono Pharmaceutical Co., Ltd. has increased its investment pool from $100 million to $200 million to continue strategic investment in Ono Venture Investment Fund I, L.P., which was established as a corporate venture capital fund in 2020. Ono established Ono Venture Investment, Inc., as well as OVI FI as local subsidiaries in the U.S. with the aim of accessing and partnering on drug discovery targets and cutting-edge technologies for the generation of innovative medicines. OVI manages the inves...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters